FITBI: Family-Implemented Treatment on the Behavioral Inflexibility of Children With Autism

Sponsor
University of Kansas (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05125003
Collaborator
(none)
100
2
48

Study Details

Study Description

Brief Summary

The overall goal of this project is to determine whether a new form of family-based treatment for repetitive and inflexible behaviors, delivered using videoconferencing technology, can counter any negative effects of those behaviors, but also improve positive outcomes for young children with ASD.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: FITBI
  • Behavioral: Parental Education
N/A

Detailed Description

The overall goal of this project is to conduct a parallel group randomized controlled trial comparing remote delivery of FITBI (12-week intervention + 3 booster sessions over 6 months) to remote delivery of a parent education only (PE) control condition in a final sample size of 100 (3-9 years) children with ASD and high rates of ritualistic repetitive behaviors. We will use TORSH, a comprehensive secure online platform that enhances therapist-parent coaching via telehealth. Further, an important objective of this proposal is to examine child and parent factors associated with treatment response and uptake in order to advance translational research and knowledge on personalized intervention approaches. Thus, the aims of this project are to:

Aim 1: Examine the acute and distal effects of the FITBI intervention on child and parent outcomes.

H1: In comparison to a PE only condition, FITBI will result in reductions in children's repetitive behaviors and increases in appropriate play skills immediately post-treatment.

H2: Effects of the FITBI intervention will be maintained at a 6-month follow-up and increases in child adaptive functioning and decreases in parent stress will be found.

Aim 2: Determine if the FITBI intervention shows differential treatment effects for lower versus higher order repetitive behaviors.

H1: FITBI will be effective at treating both lower and higher order RRBIs.

Aim 3: Examine if child variables (i.e., IQ and anxiety) moderate treatment response.

H1: Based on prior behavioral intervention research, it is hypothesized that children with higher IQs and fewer symptoms of anxiety at pretreatment, will show a better treatment response.

Aim 4: Explore if parent variables (i.e., SES, race/ethnicity, marital status, and stress) predict intervention fidelity and telehealth acceptance.

H1: As this is an exploratory aim, we do not have specific hypotheses.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Parent-implemented Treatment for Repetitive Behaviors in Children With ASD: Using a Novel Telehealth Approach to Increase Service Access.
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Mar 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: FITBI

Reinforcement-based learning procedures delivered via telehealth in15 remote-delivered treatment sessions -12 weekly and 3 booster treatment sessions over 6 month period.

Behavioral: FITBI
parents learn to identify high probability cues in the environment that can elicit RRBI symptoms and teach their child to inhibit repetitive behaviors and instead replace them with alternative and flexible play behaviors; and (b) teach parents how to embed this FITBI approach into their child's everyday routines

Active Comparator: Parent Education

Information relevant to parenting a young child with ASD (e.g. parent advocacy, developmental changes in ASD, treatment options) delivered via telehealth in15 remote-delivered treatment sessions -12 weekly and 3 booster treatment sessions over 6 month period.

Behavioral: Parental Education
Sessions will cover relevant information on young children with ASD, including understanding the ASD diagnosis, developmental changes in ASD, educational planning, advocacy, and treatment options.

Outcome Measures

Primary Outcome Measures

  1. Behavioral Inflexibility Scale - Clinical Interview [Baseline]

    video interview yields a severity score from 0 no impairment to 28 maximum impairment

  2. Behavioral Inflexibility Scale - Clinical Interview [6 weeks]

    video interview yields a severity score from 0 no impairment to 28 maximum impairment

  3. Behavioral Inflexibility Scale - Clinical Interview [12 weeks]

    video interview yields a severity score from 0 no impairment to 28 maximum impairment

  4. Behavioral Inflexibility Scale - Clinical Interview [6 months]

    video interview yields a severity score from 0 no impairment to 28 maximum impairment

Secondary Outcome Measures

  1. Aberrant Behavior Checklist-Community (ABC-C) [Baseline, 6 weeks, 12 weeks, and 6 month follow-up]

    online survey

  2. Brief Observation of Social Communication Change (BOSCC) [Baseline, 12 weeks, and 6 month follow-up]

    The BOSCC is a standardized measure of social communication change in children with ASD based on 12-minute videos of clinician- or caregiver-child interactions

  3. Behavioral Inflexibility Scale (BIS) [Baseline, 6 weeks, 12 weeks, and 6 month follow-up]

    parent survey of severity with total score ranging from 0 (no problem) to 190 very severe on all 38 items

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 9 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASD criteria on Social Communication Questionnaire-Lifetime and Autism Diagnostic Interview-Revised.

  • Between ages of 3 and 9 years

  • exhibiting clinically significant levels of repetitive behavior (Score >26 on Repetitive Behavior Scales-Revised

  • prior clinical or medical diagnosis of autism spectrum disorder

Exclusion Criteria:
  • diagnosed comorbid genetic disorder known to associated with increased symptom severity

  • child engages in serious self-injurious behavior with intensity or frequency that warrants hospitalization

  • change in psychotropic medications within last 6 weeks

  • child already receives >20hours per week of home-based ABA services

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Kansas

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Kansas
ClinicalTrials.gov Identifier:
NCT05125003
Other Study ID Numbers:
  • R01HD105036
First Posted:
Nov 18, 2021
Last Update Posted:
Nov 18, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Kansas
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2021